The 20 Best Graft Versus Host Disease (GvHD) Doctors Near Me in Bronx, NY

Ran Reshef is a Transplant Surgeon practicing medicine in New York, New York. Dr. Reshef is rated as an Elite provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Multiple Myeloma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Reshef is currently accepting new patients.

Sergio Giralt is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Giralt is rated as an Elite provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Graft Versus Host Disease (GvHD), Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Splenectomy. Dr. Giralt is currently accepting new patients.

Benedetto Bruno is a Hematologist practicing medicine in New York, New York. Dr. Bruno is rated as an Elite provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Multiple Myeloma, Leukemia, Acute Myeloid Leukemia (AML), and Bone Marrow Transplant.

John Levine is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Levine is rated as an Elite provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Smoldering Multiple Myeloma, Chronic Graft Versus Host Disease (cGvHD), Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Transplant. Dr. Levine is currently accepting new patients.

James Ferrara is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Ferrara is rated as an Elite provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Smoldering Multiple Myeloma, Immune Thrombocytopenic Purpura (ITP), and Bone Marrow Transplant.

Doris Ponce is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Ponce is rated as an Elite provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Graft Versus Host Disease (GvHD), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Transplant, and Splenectomy. Dr. Ponce is currently accepting new patients.

Roni Tamari is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Tamari is rated as an Elite provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Myelodysplastic Syndrome (MDS), Myelofibrosis, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Colonoscopy. Dr. Tamari is currently accepting new patients.

Marina Konopleva, MD, Phd, is Professor, Oncology, Professor, Molecular Pharmacology, Director, Leukemia Program and Co-Director, Blood Cancer Institute, at Montefiore Einstein. Her clinic focus centers on treating patients with hematologic malignancies, with an emphasis on acute myeloid and acute lymphoblastic leukemia. She has additional expertise in treating patients with high-risk myelodysplastic syndrome and chronic myeloid leukemia. Dr. Konopleva is rated as an Advanced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.

Prakash Satwani, MD specializes in the use of bone marrow transplantation to treat children and adolescents with leukemia, lymphoma, or hemophagocytic lymphohistiocytosis. Bone marrow transplantation is a dynamic, intriguing field with multiple complex issues. Dr. Satwani has always enjoyed solving puzzles and is attracted to the intellectual challenge of caring for patients whose lives may be saved or extended with bone marrow transplantation. Dr. Satwani is also inspired and motivated by the long-lasting and rich relationships formed with patients and their families, and often keeps in touch with families long after their child's treatment has been completed. Dr. Satwani teaches medical students, residents, fellows, nurses, and nurse practitioners about bone marrow transplantation. It's important to educate people so they can learn the latest advances and provide the best care possible for patients. To continue to achieve those advances, Dr. Satwani conducts clinical research in reducing the life-threatening complications related to transplantation, such as infections and graft-versus-host disease. Dr. Satwani and colleagues also evaluate reduced-intensity bone marrow transplantation preparative regimens, which use lower doses of chemotherapy with the hope of decreasing short-term and long-term complications without compromising the effectiveness of treatment. Dr. Satwani is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Anemia, Sickle Cell Disease, Hemophagocytic Lymphohistiocytosis, and Bone Marrow Transplant. Dr. Satwani is board certified in Pediatric Hematology-Oncology. Dr. Satwani is currently accepting new patients.

Ridhi Gupta is an Oncologist practicing medicine in Bronx, New York. Dr. Gupta is rated as an Experienced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Hemochromatosis, Zollinger-Ellison Syndrome, Richter Syndrome, and Chronic B-Cell Leukemia (CBCL).

Mahvish Q. Rahim, MD, MS, MBA, is an attending physician at the Children’s Hospital at Montefiore Einstein and Assistant Professor, Pediatrics, Pediatric Hematology-Oncology and Stem Cell Transplant at our Albert Einstein College of Medicine. Dr. Rahim’s clinical focus centers on stem cell transplant and cellular therapy for patients with leukemia and sickle cell disease. She also has an interest in fertility preservation for pediatric hematology-oncology patients. Dr. Rahim is rated as an Experienced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). Her clinical expertise encompasses Sickle Cell Disease, Acute Lymphoblastic Leukemia (ALL), Congenital Hemolytic Anemia, Hemolytic Anemia, and Bone Marrow Transplant.

Divaya Bhutani is an Internal Medicine provider practicing medicine in New York, New York. Dr. Bhutani is rated as an Advanced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Bhutani is currently accepting new patients.

Pawel Muranski is an Internal Medicine provider practicing medicine in New York, New York. Dr. Muranski is rated as an Advanced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Progressive Multifocal Leukoencephalopathy, Multiple Myeloma, Merkel Cell Carcinoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Muranski is currently accepting new patients.

Michele Donato is an Oncologist and a Hematologist practicing medicine in Hackensack, New Jersey. Dr. Donato is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 37 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Colonoscopy. Dr. Donato is board certified in American Board Of Internal Medicine.

Dr. Mapara is Professor of Medicine at Columbia University Medical Center and the Director of the Blood and Marrow Transplantation (BMT)/Cell Therapy Program at New York Presbyterian Hospital/Columbia University Medical Center. Dr. Mapara graduated from the University of Heidelberg Medical School/Germany, and received his post-graduate training in Internal Medicine and Hematology/Oncology at the Universities of Heidelberg and the University Medical Center Charite of the Humboldt University of Berlin in Germany. In addition, he completed a research fellowship at the Transplantation Biology Research Center of the Massachusetts General Hospital at the Harvard Medical School in Boston. As Assistant Professor of Medicine, he headed the Hematologic Intensive Care Unit and served as deputy director of the Stem Cell Transplantation unit at the University Medical Center Charite in Berlin, Germany. Before coming to Columbia, Dr. Mapara was Associate Professor of Medicine (with tenure) at the University of Pittsburgh Cancer Institute and served as the Director of the Adult Hematopoietic Stem Cell Transplantation Program. Dr. Mapara specializes in the care of patients with sickle cell disease and certain blood cancers (Multiple Myeloma, Amyloidosis) undergoing bone marrow transplantation and gene therapy.  His research is focused on developing novel approaches to make bone marrow transplantation and cell therapy safer for patients. Dr. Mapara is rated as an Advanced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Mapara is board certified in Hematology and Medical Oncology. Dr. Mapara is currently accepting new patients.

Ann Jakubowski is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Jakubowski is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Transplant. Dr. Jakubowski is currently accepting new patients.

Jenna Goldberg is a primary care provider, practicing in Internal Medicine in New York, New York. Dr. Goldberg is rated as an Advanced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Graft Versus Host Disease (GvHD), Mantle Cell Lymphoma (MCL), and Non-Hodgkin Lymphoma.

Alejandro Gru, MD is the Leonard C. Harber Professor of Dermatology and Director of Dermatopathology at Columbia University Irving Medical Center. He is also the Director of the Dermatopathology Fellowship and holds a joint appointment with the Pathology & Cell Biology Department. Dr. Gru received his MD from the Universidad de Buenos Aires in Argentina. He completed his internship in Medicine and residency training in Anatomic Pathology, followed by fellowship training in Surgical Pathology, Hematopathology, and Dermatopathology at Washington University School of Medicine in St. Louis. He subsequently joined the faculty at Ohio State University as an Assistant Professor of Pathology and Dermatology prior to moving to the University of Virginia, where he was promoted to Associate Professor and then tenured Professor in the Department of Pathology. At the University of Virginia, he established the first cutaneous lymphoma multidisciplinary program and served as director of the Dermatopathology section and fellowship.Dr. Gru is the current President of the United States Cutaneous Lymphoma Consortium (USCLC) and has led the pathology initiatives of the international study in advanced stage cutaneous lymphomas (PROCLIPI), the USCLC lymphoma registry, and more recently the International T-cell Lymphoma Project (TCP 2.0). He is an associate editor for the Journal of Cutaneous Pathology and Seminars in Diagnostic Pathology. He serves on the editorial board of numerous academic journals, including the Journal of the American Academy of Dermatology, the American Journal of Surgical Pathology, Modern Pathology, and Histopathology, among others. Dr. Gru is rated as an Experienced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, Erythroderma, and Tissue Biopsy. Dr. Gru is board certified in Anatomic Pathology, Dermatopathology, and Hematopathology.

"Monica Bhatia, MD specializes in the care of children with noncancerous blood disorders who may benefit from bone marrow transplantation, especially sickle cell anemia. She and her colleagues are working to reduce the toxicity (side effects) and complications of this treatment without compromising its effectiveness, and to make it available to more patients. The field of pediatric hematology brings with it many intellectual challenges, and bone marrow transplantation in particular is especially dynamic. Dr. Bhatia has the opportunity to provide care for the sickest children, potentially curing their disease. She builds strong relationships with her patients and their families that last for years. It is inspiring for her to see young patients grow up to lead healthy, productive lives. NewYork-Presbyterian/Morgan Stanley Children's Hospital has a robust program for bone marrow transplantation for sickle cell anemia - the only cure for this disease. Dr. Bhatia and her team have witnessed remarkable results among children who are cured with bone marrow transplantation and spared from the potentially life-threatening complications of sickle cell disease. Yet despite the advances made, only 15 percent of patients with sickle cell disease have a matched sibling bone marrow donor. Therefore, Dr. Bhatia and her team conduct research to evaluate a procedure called ""CD34-selected stem cell transplantation"" to remove T-cells from donor bone marrow for patients without a matched sibling donor. This approach reduces the risk of graft-versus-host disease (GVHD), a potential complication of bone marrow transplantation in which T-cells from the donor attack the tissue of the recipient. This approach to harnessing stem cells could potentially make bone marrow transplantation a safer, effective option for many patients who are seeking a cure for sickle cell disease. Dr. Bhatia and her colleagues are currently assessing reduced-intensity transplantation, which uses lower doses of chemotherapy to decrease the risk of side effects and long-term complications without lowering the effectiveness of treatment. She is also interested in looking for ways to further improve the quality of life of patients who have had a bone marrow transplant in addition to fertility preservation.". Dr. Bhatia is rated as an Experienced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). Her clinical expertise encompasses Severe Combined Immunodeficiency (SCID), X-Linked Severe Combined Immunodeficiency, Omenn Syndrome, and Sickle Cell Disease. Dr. Bhatia is board certified in Pediatrics and Pediatric Hematology-Oncology. Dr. Bhatia is currently accepting new patients.

James H. Garvin, MD, PhD, is a board-certified pediatric hematologist-oncologist who specializes in the care of children and adolescents with brain tumors. He is Principal Investigator at CUMC for the Head Start Program of radiation-sparing intensive chemotherapy for infants and young children with brain tumors. He was principal investigator for a Children's Oncolgy Group protocol for childhood ependymoma. He also offers novel therapies for recurrent brain tumors through our program's membership in Developmental Therapeutics Program of the COG. In addition, Dr. Garvin started the pediatric bone marrow transplant program, and continues as a member of the BMT group. He has particular interest in autologous transplant for brain tumors and allogeneic transplant for metabolic disorders and bone marrow failure syndromes, as well as supportive care for BMT patients. Dr. Garvin became interested in pediatric hematology/oncology through research during medical school in the laboratory of a pediatric hematologist. He is a member of numerous professional societies in the field. Dr. Garvin is rated as an Experienced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). His clinical expertise encompasses Brain Stem Cancer, Medulloblastoma, Glioma, Chronic Graft Versus Host Disease (cGvHD), and Bone Marrow Transplant. Dr. Garvin is board certified in Pediatrics and Pediatric Hematology-Oncology. Dr. Garvin is currently accepting new patients.